×
About 3,628 results

ALLMedicine™ Aortic Regurgitation Center

Research & Reviews  1,315 results

Percutaneous closure of ventricular septal defect using LifeTechTM Konar-MF VSD Occlude...
https://doi.org/10.1017/S1047951121002985
Cardiology in the Young; Sadiq M, Qureshi AU et. al.

Jul 29th, 2021 - Transcatheter ventricular septal defect closure remains a complex procedure with potential complications like complete heart block and aortic regurgitation. The ideal device design for such intervention is still evolving. To assess the safety, eff...

Early clinical and haemodynamic matched comparison of balloon-expandable valves.
https://doi.org/10.1136/heartjnl-2021-319349
Heart (British Cardiac Society); Delgado-Arana JR, Gordillo-Monge MX et. al.

Jul 22nd, 2021 - The balloon-expandable Sapien-3 valve demonstrated superior results in terms of residual aortic regurgitation when compared with self-expandable devices. We aimed to compare for the first-time early outcomes of Sapien-3 transcatheter heart valve (...

Diagnostic value of vena contracta area measurement using three-dimensional transesopha...
https://doi.org/10.1111/echo.15144
Echocardiography (Mount Kisco, N.Y.); Yanagi Y, Kanzaki H et. al.

Jul 22nd, 2021 - Transthoracic echocardiography (TTE) provides noninvasively quantitative assessment of aortic regurgitation (AR) severity, but its diagnostic accuracy depends on image quality. Two-dimensional transesophageal echocardiography (TEE) is a semi-invas...

David operation for insufficient pulmonary autograft after Ross-Konno procedure.
https://doi.org/10.1016/j.athoracsur.2021.07.005
The Annals of Thoracic Surgery; Takura M, Eishi K et. al.

Jul 21st, 2021 - We report the case of a 25-year-old female who developed severe aortic regurgitation because of pulmonary autograft root dilatation late after Ross-Konno procedure. The geometric heights of all three cusps were relatively small, allowing for the D...

see more →

Clinicaltrials.gov  16 results

Biomarkers in Aortic Stenosis - B.A.S.S.
https://clinicaltrials.gov/ct2/show/NCT01334801

Apr 22nd, 2019 - Patients with aortic stenosis, hypertrophic cardiomyopathy, mitral regurgitation, aortic regurgitation, artificial heart valve regurgitation or stenosis, and tricuspid valve regurgitation associated with pacemaker leads who are referred for clinic...

PRospective Observation of Aortic reGuRgitation aftEr TAVI and progreSS Over Time: PROGRESS PVL Registry
https://clinicaltrials.gov/ct2/show/NCT02987894

Nov 1st, 2018 - The primary objective of this post-market registry is to further evaluate the safety and performance of the ACURATE neo™ Aortic Bioprosthesis and the ACURATE TF™ Transferral Delivery System in 500 consented patients with severe aortic stenosis and...

Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation
https://clinicaltrials.gov/ct2/show/NCT03025971

Aug 23rd, 2018 - To evaluate the safety and efficacy of the J-Valve Ausper system for the treatment of patients with severe aortic stenosis and/or aortic regurgitation with elevated risk for surgery.

Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.
https://clinicaltrials.gov/ct2/show/NCT03644784

Aug 23rd, 2018 - The ASSESS-REGURGE is a multicenter, multicontinental registry on protocoled aortographic image acquisition after implantation of a transcatheter aortic valve. After the implementation of the acquisition protocol, each participating site will use ...

BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.
https://clinicaltrials.gov/ct2/show/NCT03495050

Jun 12th, 2018 - Study Design Study Design: prospective non-interventional multicenter registry Screening: MSCT submitted to core lab & sizing strategy pre-declared (annular sizing, supra-annular sizing, mix of both methods) Follow up: MSCT and TTE to cooper lab T...

see more →

News  118 results

Valve-in-Valve TAVR Outcomes Better in Failed TAVR vs SAVR
https://www.medscape.com/viewarticle/944041

Jan 13th, 2021 - Transcatheter valve-in-valve replacement of a transcatheter aortic valve, so-called TAV-in-TAV, appears to offer procedural success that is better than, and procedural safety and mortality that are similar to, transcatheter valve-in-valve replacem...

MHRA Highlights Risk of Heart Valve Regurgitation with Fluoroquinolones
https://www.medscape.com/viewarticle/943287

Dec 29th, 2020 - The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update highlighting a small risk of heart valve regurgitation with the use of systemic and inhaled fluoroquinolones. The update follows a European review of ep...

LV Volume May Work as Well as Linear Measures in Pinpointing Aortic Regurgitation Mortality Risk
https://www.medscape.com/viewarticle/940744

Nov 11th, 2020 - NEW YORK (Reuters Health) - In asymptomatic patients with chronic aortic regurgitation (AR), left ventricular end-systolic volume index (LVESVi) and volume-derived LV ejection fraction (Vol-LVEF) work as well as LV end-systolic dimension index (LV...

New SCOPE Data Put ACURATE neo on the Back Foot Again
https://www.medscape.com/viewarticle/939539

Oct 21st, 2020 - ACURATE neo's (Boston Scientific) place in the treatment of severe aortic stenosis is unclear after failing to show noninferiority in a head-to-head comparison with another self-expanding, supra-annular transcatheter valve and reporting lackluster...

Quantifying the Effects of LVOT Calcification After TAVR
https://www.medscape.com/viewarticle/935075

Aug 3rd, 2020 - A new SWISS TAVI registry analysis provides some of the strongest evidence to date that the presence of left ventricular outflow tract (LVOT) calcification is a harbinger of worse outcomes in transcatheter aortic valve replacement (TAVR). Among 16...

see more →

Patient Education  2 results see all →